These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 15461871)

  • 41. Sustained clinical response in psoriatic arthritis patients treated with anti-TNF agents: a 5-year open-label observational cohort study.
    Saougou I; Markatseli TE; Papagoras C; Voulgari PV; Alamanos Y; Drosos AA
    Semin Arthritis Rheum; 2011 Apr; 40(5):398-406. PubMed ID: 20843542
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Infliximab for the treatment of psoriasis: clinical experience at the State University of New York at Buffalo.
    Kalb RE; Gurske J
    J Am Acad Dermatol; 2005 Oct; 53(4):616-22. PubMed ID: 16198781
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Resolution of endothelial activation and down-regulation of Tie2 receptor in psoriatic skin after infliximab therapy.
    Markham T; Mullan R; Golden-Mason L; Rogers S; Bresnihan B; Fitzgerald O; Fearon U; Veale DJ
    J Am Acad Dermatol; 2006 Jun; 54(6):1003-12. PubMed ID: 16713454
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Striking and rapid improvement of plaque psoriasis with infliximab. A report of two cases.
    Al-Salem IH
    Dermatology; 2003; 207(1):54-6. PubMed ID: 12835550
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Infliximab treatment results in significant improvement in the quality of life of patients with severe psoriasis: a double-blind placebo-controlled trial.
    Feldman SR; Gordon KB; Bala M; Evans R; Li S; Dooley LT; Guzzo C; Patel K; Menter A; Gottlieb AB
    Br J Dermatol; 2005 May; 152(5):954-60. PubMed ID: 15888152
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy and safety of infliximab vs. methotrexate in patients with moderate-to-severe plaque psoriasis: results of an open-label, active-controlled, randomized trial (RESTORE1).
    Barker J; Hoffmann M; Wozel G; Ortonne JP; Zheng H; van Hoogstraten H; Reich K
    Br J Dermatol; 2011 Nov; 165(5):1109-17. PubMed ID: 21910713
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of infliximab on health-related quality of life and disease activity by body region in patients with moderate-to-severe psoriasis and inadequate response to etanercept: results from the PSUNRISE trial.
    Kalb RE; Blauvelt A; Sofen HL; Chevrier M; Amato D; Calabro S; Wang J; Schenkel B; Gottlieb AB
    J Drugs Dermatol; 2013 Aug; 12(8):874-80. PubMed ID: 23986160
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Open-label study of infliximab treatment for psoriatic arthritis: clinical and magnetic resonance imaging measurements of reduction of inflammation.
    Antoni C; Dechant C; Hanns-Martin Lorenz PD; Wendler J; Ogilvie A; Lueftl M; Kalden-Nemeth D; Kalden JR; Manger B
    Arthritis Rheum; 2002 Oct; 47(5):506-12. PubMed ID: 12382299
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial.
    Chaudhari U; Romano P; Mulcahy LD; Dooley LT; Baker DG; Gottlieb AB
    Lancet; 2001 Jun; 357(9271):1842-7. PubMed ID: 11410193
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biologic therapy (TNF-alpha antagonists)-induced psoriasis: a cytokine imbalance between TNF-alpha and IFN-alpha?
    Cuchacovich R; Espinoza CG; Virk Z; Espinoza LR
    J Clin Rheumatol; 2008 Dec; 14(6):353-6. PubMed ID: 19033869
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Psoriasis onset during infliximab treatment: description of two cases.
    Volpe A; Caramaschi P; Carletto A; Pieropan S; Bambara LM; Biasi D
    Rheumatol Int; 2006 Oct; 26(12):1158-60. PubMed ID: 16738903
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Efficacy of infliximab in patients with moderate and severe psoriasis treated with infliximab (Remicade)].
    Valdés A Mdel P; Schroeder H F; Roizen G V; Honeyman M J; Sánchez M L
    Rev Med Chil; 2006 Mar; 134(3):326-31. PubMed ID: 16676105
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Repeated infusions of low-dose infliximab plus methotrexate in psoriatic arthritis: immediate benefits are not maintained after discontinuation of infliximab.
    Covelli M; Scioscia C; Iannone F; Lapadula G
    Clin Exp Rheumatol; 2005; 23(2):145-51. PubMed ID: 15895882
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term maintenance treatment of moderate-to-severe plaque psoriasis with infliximab in combination with methotrexate or azathioprine in a retrospective cohort.
    Dalaker M; Bonesrønning JH
    J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):277-82. PubMed ID: 19207642
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Infliximab monotherapy provides rapid and sustained benefit for plaque-type psoriasis.
    Gottlieb AB; Chaudhari U; Mulcahy LD; Li S; Dooley LT; Baker DG
    J Am Acad Dermatol; 2003 Jun; 48(6):829-35. PubMed ID: 12789171
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adverse reactions during biological drug therapy in psoriasis:clinical series and a review of the literature.
    Montesu MA; Addis GM; Satta R; Cottoni F
    G Ital Dermatol Venereol; 2011 Aug; 146(4):273-81. PubMed ID: 21785393
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development of a preliminary US power Doppler composite score for monitoring treatment in PsA.
    Gutierrez M; Di Geso L; Salaffi F; Bertolazzi C; Tardella M; Filosa G; Filippucci E; Grassi W
    Rheumatology (Oxford); 2012 Jul; 51(7):1261-8. PubMed ID: 22378715
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Golimumab for the treatment of psoriatic arthritis.
    Yang H; Epstein D; Bojke L; Craig D; Light K; Bruce I; Sculpher M; Woolacott N
    Health Technol Assess; 2011 May; 15 Suppl 1():87-95. PubMed ID: 21609657
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Infliximab in recalcitrant generalized pustular arthropatic psoriasis.
    Vieira Serrão V; Martins A; Lopes MJ
    Eur J Dermatol; 2008; 18(1):71-3. PubMed ID: 18086593
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Infliximab for the treatment of psoriasis in the U.K.: 9 years' experience of infusion reactions at a single centre.
    Wee JS; Petrof G; Jackson K; Barker JN; Smith CH
    Br J Dermatol; 2012 Aug; 167(2):411-6. PubMed ID: 22404545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.